US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT06355791 N/A
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated Wit...
Condition
Degenerative Conditions of the Lumbar Spine
Enrollment
150 pts
Location
United States
Sponsor
Spinal Simplicity LLC
View Trial →
NCT07437950 Phase 2
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly ...
Condition
Acute Myeloid Leukemia
Enrollment
126 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05604131 Phase 2
Recruiting
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Condition
Acute Myocardial Infarction Type 1
Enrollment
89 pts
Location
United States
Sponsor
Rohan Dharmakumar
View Trial →
NCT05413421 Phase 1
Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Condition
Metastatic Prostate Cancer
Enrollment
275 pts
Location
United States, Australia, Spain
Sponsor
ORIC Pharmaceuticals
View Trial →
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06401421 N/A
Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Brea...
Condition
Breast Cancer
Enrollment
1,800 pts
Location
United States, Canada
Sponsor
Exact Sciences Corporation
View Trial →
NCT07440225 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Argentina, Australia
Sponsor
EyeBiotech Ltd.
View Trial →
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06256588 Phase 3
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants Wit...
Condition
Neoplasms, Head and Neck
Enrollment
864 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT05346796 N/A
Recruiting
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Condition
Cancer
Enrollment
250 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06040827 N/A
Recruiting
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturi...
Condition
Knee Osteoarthritis
Enrollment
626 pts
Location
United States
Sponsor
Canary Medical
View Trial →
NCT06465069 Phase 1
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Canc...
Condition
Metastatic Solid Tumor
Enrollment
460 pts
Location
United States, Australia, China
Sponsor
Eli Lilly and Company
View Trial →
NCT06399692 Phase 3
Recruiting
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARG...
Condition
Coronary Artery Disease
Enrollment
600 pts
Location
United States
Sponsor
Weill Medical College of Corne
View Trial →
NCT06207032 N/A
Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Condition
Cancer
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Tempus AI
View Trial →
NCT07223593 Phase 3
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disea...
Condition
Peripheral Arterial Disease
Enrollment
1,205 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT07318558 Phase 3
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Can...
Condition
Ovarian Neoplasms
Enrollment
900 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130...
Condition
Chronic Kidney Disease
Enrollment
465 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT07782333 Phase 2
Recruiting
A Study Evaluating TRIV-573 in Atopic Dermatitis
Condition
Atopic Dermatitis
Enrollment
90 pts
Location
United States, Canada, Ukraine
Sponsor
Triveni Bio
View Trial →
NCT06261346 N/A
Recruiting
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
Condition
Fuchs' Endothelial Dystrophy
Enrollment
100 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT06810505 Phase 3
Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease...
Condition
Chronic Migraine
Enrollment
420 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
View Trial →
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
474 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
Page 6 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology